Vaginal Atrophy (GSM) Solutions Doctor-Led, Evidence-Informed
Quick Answer: GSM causes dryness, pain, and urinary issues due to low oestrogen. We offer evidence-informed care ranging from NICE-recommended vaginal oestrogen to regenerative options like Laser, PRP, and HA for selected cases.
For many women, it isn't "just dryness." It can affect the bladder and urethra, leading to urinary urgency or recurrent UTIs alongside intimate discomfort. We don't use a one-size-fits-all approach; we start with a clinical assessment to understand your specific symptoms.
Why Women Choose Our Clinic
Practitioner-Led Care
Treatments by Dr Farzana Khan.
Medical Oversight
Governance by Dr Kamaljit Singh.
Treatment at a Glance
Condition
Vaginal Atrophy / GSM
Methods
Laser, PRP, HA, or Estrogen
Downtime
Minimal / Protocol Dependent
Recovery
Often immediate return to routine
Evidence-Informed
Transparent Governance
Personalised Assessment with Our GP-Led Team
Every journey begins with understanding. We start with a clinical assessment to understand your specific pattern of symptoms, medical history, and treatment goals before discussing options.
What is Genitourinary Syndrome of Menopause?
Formally termed GSM, this condition describes a collection of symptoms affecting the vulva, vagina, bladder and urethra due to declining oestrogen levels. It is not just "dryness"—it is a medical condition involving tissue changes.
The Symptoms
Daily ImpactPersistent discomfort that doesn't improve with standard lubricants and can involve urinary issues.
- Soreness, burning, or stinging
- Discomfort/Pain with intimacy
- Recurrent UTIs or Urgency
Tissue Changes
Medical PictureLow oestrogen causes the vaginal lining to become thinner, less elastic, and produce less natural moisture.
- Epithelial thinning & fragility
- Loss of collagen & elastin
- pH rises (loss of protection)
Quality of Life
Emotional CostFrom relationship strain to anxiety about urinary leaks, the impact extends far beyond physical discomfort.
*GSM is typically progressive without treatment.
Causes & Prevalence: A Progressive Condition
The Driver: Oestrogen decline reduces tissue elasticity and moisture. This isn't limited to natural menopause; surgical removal of ovaries, breastfeeding, or cancer treatments can trigger sudden onset.
The Scale: Studies suggest up to 50-70% of women experience symptoms. Crucially, unlike hot flushes which often settle, vaginal atrophy is typically progressive and worsens over time without intervention.
Medical Note: Early intervention often means better outcomes and preventing progression to more severe symptoms.
Who Can Benefit From Treatment?
You might benefit from assessment if you experience persistent dryness, burning, or pain that affects your daily life. This includes women across various life stages, not just natural menopause.
Menopause & Perimenopause
The most common pathway to GSM as natural oestrogen production declines, causing tissue thinning.
Post-Partum Mothers
Breastfeeding creates a temporary low-oestrogen state that can cause symptoms similar to menopause.
Surgical Menopause
Hysterectomy with ovarian removal causes immediate oestrogen loss, often with more severe symptoms.
Cancer Survivors
Breast or ovarian cancer treatments may limit hormone options, making non-hormonal support vital.
Medication Users
Women on anti-oestrogen therapies (Tamoxifen, etc.) or treatments for endometriosis.
Recurrent UTIs
Urogenital atrophy often presents as frequent urinary infections or urgency.
It's More Than Just Dryness
GSM can involve surface discomfort, tissue fragility, and urogenital changes like urgency or recurrent UTIs. That is why some women need a step-up plan rather than a single product.
Discuss Your SymptomsSymptom Relief vs. Tissue Regeneration
Lubricants may help with friction during sex, but they don't address underlying tissue quality, pH balance, or urinary symptoms. We focus on restoring health.
Treating vs. Masking Symptoms
The Progression Without Treatment
NICE Guidance & Laser Transparency
Evidence-Based
Transparent Care
Evidence-Informed Choice
We discuss what's established in national guidance (vaginal oestrogen) versus what's promising but emerging (PRP, Laser), so you can make decisions with full awareness.
Non-Hormonal Options
For women who cannot or prefer not to use hormonal treatments, we offer biologic and regenerative pathways like PRP and Hyaluronic Acid therapy.
Regenerative Focus
Our regenerative treatments aim to stimulate fibroblasts, increase blood vessel formation, and promote tissue remodelling rather than just masking symptoms.
Holistic Assessment
We consider your full history—including medications, lifestyle, and pelvic health—to create a plan that fits your specific physiology and recovery goals.
Evidence-Based Results
While self-care measures like moisturisers help, established atrophy often requires medical treatment. Delayed treatment allows atrophy to progress, making it harder to treat later.
Start Your Journey
Pricing for Vaginal Atrophy Treatments
Vaginal Laser Course
Fractional CO₂ laser for vaginal atrophy — structured as a course (suitability assessed at consultation).
session
- Doctor led: Laser £799 per session £1,800 for 3
Nurse led: Laser £599 per session or £1,200 for 3 - Clinician-led assessment, clear counselling and written aftercare
- Course-based approach with optional maintenance if needed (results vary)
- Can be combined with PRP/boosters for a personalised plan where appropriate
Menu (single sessions & add-ons)
Course of 3 £2,985 £1,110
Course of 2 £1,400 £795
Course of 4 £2,300 £699
Course of 3 £2,450 £895
Vulval skin tightening £699 Final recommendations and any combination plans are confirmed after assessment.
Intimate Makeover
Combination package including 2* PRP, HA skin booster, and 2 laser sessions — tailored after consultation (treatment mix may vary by suitability).
£2,999
Discuss the PackageUnsure Which Option is Right For You?
You don't need to decide alone. Our GP-led team offers a comprehensive medical assessment to review your symptoms and recommend the safest plan.
Book Medical Assessment
Concern and Safety – Contraindications
We adhere to a universal "pause and assess first" policy to ensure your safety and suitability for treatment.
Absolute Contraindications
We won't proceed with any GSM treatment if you have:
- Undiagnosed Bleeding: Especially post-menopausal bleeding, which requires investigation first.
- Active Infection: Bacterial vaginosis, thrush, STIs, or PID.
- Suspected Malignancy: Until appropriate cancer investigation and clearance is obtained.
- Pregnancy: Assessment welcome, but treatment is deferred to the post-partum period.
Requires Discussion
Specific treatments may need careful review if you have:
Confidential Medical Review
Most conditions do not rule out treatment but may change the choice of technology used. We can liaise with your oncology team or specialist to ensure appropriate care.
Disclaimer: This list is not exhaustive. A full medical history is taken during your consultation. Information provided on this site is for educational purposes and does not constitute medical advice.
Unsure Which Option is Right For You?
You don't need to decide alone. Our GP-led team offers a comprehensive medical assessment to review your symptoms and recommend the safest plan.
Treatment FAQs
Everything you need to know about the procedure and recovery.
Is vaginal atrophy the same as vaginal dryness?
Do urinary symptoms (urgency/UTIs) really link to GSM?
What's the most established treatment in UK guidance?
Is laser "proven" for GSM?
Can I choose a non-hormonal plan?
Will vaginal oestrogen cause systemic hormonal effects?
How quickly will I see improvement?
Is GSM treatment permanent or will I need ongoing maintenance?
Can I combine treatments?
I had breast cancer – can I have any of these treatments?
What if I've tried vaginal oestrogen and it hasn't worked?
Are there any long-term risks with these treatments?
Have a specific question?
Our medical team is happy to discuss your specific concerns in a private setting.
Ask a Medical ProfessionalLifestyle Support & Common Myths
Method 1: Transvaginal Laser (Mechanism & Protocol)
The Mechanism: The laser delivers controlled thermal energy to the vaginal lining. This micro-injury intends to stimulate fibroblasts (collagen-producing cells) and increase blood vessel formation (neovascularisation), promoting tissue remodelling[cite: 207].
The Protocol: Most protocols involve 3 sessions spaced 4–6 weeks apart. A small probe delivers 360-degree treatment, typically taking 5-15 minutes with no anaesthesia required [cite: 205, 208-209].
Clinical Note: As per NICE IPG697, we use this only in a research-governed context due to the need for more long-term efficacy data[cite: 213].
Method 2: PRP (Platelet-Rich Plasma) Science
Biological Theory: We concentrate your own blood's platelets, which contain growth factors like PDGF and VEGF. When injected, these are thought to attract stem cells and trigger natural tissue regeneration and blood flow improvements [cite: 220-221].
Evidence Status: PRP is an emerging biologic option. Pilot studies report improvements in the Vaginal Health Index and dyspareunia, but large-scale long-term trials are still developing[cite: 223].
Method 3: Hyaluronic Acid (Deep Hydration)
How it works: Hyaluronic acid (HA) is a naturally occurring molecule that holds up to 1,000 times its weight in water. Unlike surface moisturisers, injectable HA is placed within tissue layers to provide deep cushioning, hydration, and support for elasticity [cite: 226-228].
Best For: Women seeking immediate non-hormonal hydration or those with contraindications to oestrogen[cite: 235].
Method 4: Exosomes (Investigational)
The Concept: Exosomes are cellular "messaging packages" containing proteins and signalling molecules that facilitate cell-to-cell communication. They are theorised to deliver regenerative signals that modulate inflammation and promote healing [cite: 236-238].
Regulatory Status: This is strictly an investigational treatment. We only discuss this where there is a clear clinical rationale, with full transparency about the lack of long-term data and current UK regulatory considerations [cite: 240-243].
Daily Habits That Help
Regular use of vaginal moisturisers (2-3 times weekly, not just before sex) helps maintain baseline hydration. Use water-based lubricants during intimacy to reduce friction. Avoid perfumed products, harsh soaps, douching, or tight synthetic clothing. Staying hydrated and maintaining regular sexual activity (where comfortable) also supports tissue elasticity ("use it or lose it" principle).
Common Myths Debunked
- "It's just part of ageing": False. Symptoms are treatable, not something you must endure.
- "Only old women get it": False. It affects younger women after surgical menopause, breastfeeding, or cancer treatment.
- "Lubricant solves the problem": False. Lubricants reduce friction but don't fix underlying tissue thinning or pH changes.
- "It means you're not aroused": False. Arousal is different from tissue health; even aroused tissues can remain dry and fragile.
Impact on Daily Life
The burden is often hidden. Pain during sex can cause relationship strain and anxiety. Persistent burning or urinary urgency can interfere with work, exercise, and social confidence. Many women delay seeking help due to embarrassment, but your symptoms are real, valid, and treatable.
Clinical References & Citations
- 1. NICE IPG697: Transvaginal laser therapy for urogenital atrophy. View Guidance
- 2. NICE NG23: Menopause: identification and management. View Guidance
- 3. NICE IPG697: Recommendations. View Guidance
- 4. FDA Warns Against Use of Energy-Based Devices. View Communication
- 5. PubMed: Role of Platelet-Rich Plasma in Genitourinary Syndrome. View Study
- 6. PMC: Navigating the Global Regulatory Landscape for Exosomes. View Article
- 7. WSH NHS: Atrophic vaginitis genitourinary syndrome of the menopause. View Leaflet
- 8. British Menopause Society: Genitourinary Syndrome of Menopause (GSM). View Statement
- 9. PMC: A randomized, pilot trial comparing vaginal hyaluronic acid. View Study